We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PVH icon
151
PVH
PVH
$3.71B
$10.4M 0.18%
76,053
+56,152
+282% +$7.34M
MKC icon
152
McCormick & Company Non-Voting
MKC
$13.4B
$10.3M 0.18%
201,574
-139,754
-41% -$6.96M
COTY icon
153
Coty
COTY
$2.33B
$10.2M 0.18%
513,548
-60,653
-11% -$1.04M
DXC icon
154
DXC Technology
DXC
$1.63B
$10M 0.17%
122,398
-7,687
-6% -$621K
IRBT
155
DELISTED
iRobot
IRBT
$9.71M 0.17%
+126,601
New +$9.12M
COHR
156
DELISTED
Coherent Inc
COHR
$9.63M 0.17%
34,125
-3,693
-10% -$1.03M
NKTR icon
157
Nektar Therapeutics
NKTR
$2.39B
$9.62M 0.17%
10,733
-6,594
-38% -$3.9M
SYK icon
158
Stryker
SYK
$127B
$9.57M 0.17%
61,796
+14,000
+29% +$2.14M
HOLI
159
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$9.51M 0.16%
427,067
+73,834
+21% +$1.7M
NEM icon
160
Newmont
NEM
$98.2B
$9.48M 0.16%
252,740
+132,963
+111% +$4.89M
PWR icon
161
Quanta Services
PWR
$93.9B
$9.48M 0.16%
+242,347
New +$9.09M
SYF icon
162
Synchrony
SYF
$23.7B
$9.21M 0.16%
238,511
+389
+0.2% +$13.3K
PSX icon
163
Phillips 66
PSX
$82.9B
$9.21M 0.16%
91,021
+14,855
+20% +$1.41M
PYPL icon
164
PayPal
PYPL
$49.5B
$9.13M 0.16%
123,989
-130,980
-51% -$9.47M
COO icon
165
Cooper Companies
COO
$13.7B
$9.12M 0.16%
167,392
+76,240
+84% +$4.46M
FLS icon
166
Flowserve
FLS
$9.25B
$9.08M 0.16%
+215,428
New +$9.02M
CM icon
167
Canadian Imperial Bank of Commerce
CM
$107B
$9M 0.16%
184,096
-105,838
-37% -$4.82M
IMMU
168
DELISTED
Immunomedics Inc
IMMU
$8.97M 0.16%
555,000
+60,500
+12% +$714K
TMO icon
169
Thermo Fisher Scientific
TMO
$211B
$8.97M 0.16%
47,230
+406
+0.9% +$77.8K
IP icon
170
International Paper
IP
$22.3B
$8.92M 0.15%
162,496
-111,664
-41% -$5.99M
PANW icon
171
Palo Alto Networks
PANW
$264B
$8.84M 0.15%
365,892
+65,406
+22% +$1.59M
SPLK
172
DELISTED
Splunk Inc
SPLK
$8.78M 0.15%
105,943
+20,779
+24% +$1.52M
VMC icon
173
Vulcan Materials
VMC
$36.3B
$8.69M 0.15%
67,622
-5,278
-7% -$645K
AIZ icon
174
Assurant
AIZ
$13.7B
$8.67M 0.15%
85,984
-44,520
-34% -$4.4M
LJPC
175
DELISTED
La Jolla Pharmaceutical Company
LJPC
$8.66M 0.15%
269,000
+88,000
+49% +$2.88M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.